In the context of neurodegenerative diseases, ADAM17 is mainly implicated in the pathology of Alzheimer’s disease (AD), a progressive disorder characterized by cognitive dysfunction and amyloid β (Aβ) accumulation (Qian et al., 2016). Here, ADAM17 is linked to Alzheimer disease.